Woodline Partners LP - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 104 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,863,000
-71.3%
208,399
+12.5%
0.03%
-74.5%
Q3 2021$6,495,000
+61.0%
185,265
-1.4%
0.11%
+41.3%
Q2 2021$4,034,000
-69.7%
187,805
-12.9%
0.08%
-74.6%
Q1 2021$13,318,000
+15.5%
215,673
-21.9%
0.30%
-3.6%
Q4 2020$11,535,000276,0830.31%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$4,712,40033.11%
BML Capital Management, LLC 2,236,239$8,363,5347.52%
TANG CAPITAL MANAGEMENT LLC 3,026,455$11,318,9421.67%
Stonepine Capital Management, LLC 752,088$2,812,8091.02%
Bain Capital Life Sciences Investors, LLC 2,485,638$9,296,2860.96%
CM Management, LLC 250,000$9350.91%
EcoR1 Capital, LLC 6,995,861$26,164,5200.64%
Cormorant Asset Management, LP 1,547,181$5,786,4570.32%
SECTORAL ASSET MANAGEMENT INC 501,537$1,875,7480.31%
Auour Investments LLC 177,000$661,9800.28%
View complete list of ATEA PHARMACEUTICALS INC shareholders